Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IOVA
IOVA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IOVA News
IOVA Benefits from Rival Drug Rejection, Analysts Bullish
Apr 10 2026
stocktwits
Investment Outlook for Iovance Biotherapeutics
Apr 10 2026
Fool
Iovance Biotherapeutics Sees Rapid Sales Growth Amid Risks
Apr 10 2026
NASDAQ.COM
REPL and IOVA Await FDA Decision Amid Market Dynamics
Apr 10 2026
stocktwits
Iovance Shares Surge 16% as FDA Decision on Replimune Approaches
Apr 09 2026
stocktwits
Avaí Bio Initiates Master Cell Bank Manufacturing
Apr 01 2026
Newsfilter
Avaí Bio Initiates Master Cell Bank Manufacturing
Apr 01 2026
PRnewswire
Avaí Bio Initiates Key Cell Bank Project for Therapy Development
Mar 24 2026
PRnewswire
Avaí Bio Initiates Key Cell Bank Project for Therapy Development
Mar 24 2026
Newsfilter
How Two Small Biotech Companies Could Pave the Way for Innovative Cancer Therapies
Mar 12 2026
Marketbeat
Iovance Biotherapeutics Stock Rises Amid High Short Interest
Mar 06 2026
Benzinga
Iovance Biotherapeutics: High-Risk, High-Reward Potential
Mar 05 2026
Fool
Iovance Biotherapeutics Faces Challenges and Opportunities
Mar 05 2026
NASDAQ.COM
ImmunityBio and Iovance Stock Dynamics Analysis
Mar 05 2026
stocktwits
Wall Street Analysts Adjust Ratings on Key Stocks
Mar 03 2026
Benzinga
Significant Milestones in Biotech Sector This Week
Feb 27 2026
NASDAQ.COM
Show More News
